Clinical Trials List
Protocol NumberHCB101-201
Not yet recruiting
2026-03-01 - 2029-06-30
Phase I/II
Recruiting1
-
Trial Applicant
STATPLUS, INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
56 participants
-
Global
560 participants
